Novo Nordisk just celebrated 50 years in France; what have been some of the more recent events that have marked the affiliate’s time here? If…

Mexico is number one in child obesity and number two in adult obesity in the world. This is one of the reasons that diabetes is rapidly increasing and…

Novo Nordisk is one of the very few pharmaceutical multinationals that have a strong focus on one therapeutic area. Although the company has a…

We found a Capital Markets Day presentation from Novo Nordisk that talked about the “rule of halves” – that of all people with…

Novo Nordisk’s largest insulin production facility outside of Denmark is in Latin America, in Brazil. Can you explain the strategic importance…

We understand that you have been with Novo Nordisk for quite a while already. In the past decade, you also did not sit still in terms of location,…

Novo Nordisk has a long history in Serbia compared to many of the other multinational companies present in the country today. The separate entity Novo…

Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was telling us that the main…

This year’s Q1 results for Novo Nordisk were extremely positive with a 23% increase in profit. While this growth was mostly driven by the US and…

Given that Asia is leading growth in the global pharmaceutical market, how is Novo Nordisk represented in the Asia-Pacific region and what is the…

Novo Nordisk is one of the few pharmaceutical multinationals focused in one key therapeutic area. Perhaps you could start by telling our readers about…

Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in emerging markets, due to the…